2D-Molecular homology modeling of selected Enolase enzyme for Leishmaniasis

Authors

  • Jayprakash Mahato Sri Satya Sai University of Technology & Medical Sciences Bhopal-Indore Road, Sehore, Madhya Pradesh-466001
  • R Sivaperumal Sri Satya Sai University of Technology & Medical Sciences Bhopal-Indore Road, Sehore, Madhya Pradesh-466001

Abstract

In present study, BLAST search was performed and an identity with Trypanosoma brueei is 79% Based upon and Pfam results Enolase- 2PTZ (protein data bank) was considered as an ideal homologue and used as a template for homology modeling due to its higher X-ray resolution at 1.65. Sequence alignment between enolase and 2PTZ was done using align 123 followed by manual modification. The final alignment was carefully evaluated and evidenced to be matching the conserved residue data for chain A of enolase in Trypanosoma brucei well Superimposing of the model was done over the template 2PTZ. Further research on the comparison of the models for the inhibitors may eluciadate the mechanism of enolase ligands interactions. This study has shown that some formation of favorable hydrogen bonds, hence it is predicated from this study that these novel compounds may act as potent inhibitors for Leishmania Enolase. These compounds may be used further for synthesis, their wet lab activity against Enolase, animal model study and clinical trials and then can be implicated for the treatment of leishmaniasis. Those models are considered to be used in designing new leads for hopefully more active compounds.

Keywords: Enolase, Leishmaniasis, Enzyme, 2D-moleculare Modeling

DOI

https://doi.org/10.22270/jddt.v8i6-s.2117

Author Biographies

Jayprakash Mahato, Sri Satya Sai University of Technology & Medical Sciences Bhopal-Indore Road, Sehore, Madhya Pradesh-466001

Sri Satya Sai University of Technology & Medical Sciences Bhopal-Indore Road, Sehore, Madhya Pradesh-466001

R Sivaperumal, Sri Satya Sai University of Technology & Medical Sciences Bhopal-Indore Road, Sehore, Madhya Pradesh-466001

Sri Satya Sai University of Technology & Medical Sciences Bhopal-Indore Road, Sehore, Madhya Pradesh-466001

References

Mauricio I. L., Stothard J. R., Miles M. A., The strange case of Leishmania chagasi, Parasitol. Today. 2000; 16:188-189.

Alvar J., Canavate C., Molina R., Moreno J., Nieto J., Leishmaniasis. Adv. Parasitol. 2004; 57:1-88.

Wolday D., Berhe N., Akuffo H., Desjeus P.,9 Britton S., Emerging Leishmania/HIV co-infection in Africa. Medical Microbiology and Immunology (Berlin). 2001; 190:65-67.

Seaman J., Mercer A. J., Sondorp E., The epidemic of visceral leishmaniasis in western Uppernile, southern Sudan course and impact from 1984 to 1994. Int. J. Epidemiol. 1996; 25:862-871.

Alvar J., Yactayo S., Bern C, Leishmaniasis and poverty. Trends Parasitol., 2006; 22:552-557.

www.uni-tuebingen.de/..Mode_Leish_Cycle_en.html.

Killick-Kendrick R., Molineus W., Transmission of leishmaniasis by thebite of a phlebotomine, possible mechanisms. Trans R. Soc Trop Med. Hyg, 1981; 75:152-154.

Francois, S., Sundar, s., Hailu, A., Ghalib, H., Rija, S., Rosanna, W. P., Alvar, J., and Boelaet, M., Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Review, Microbiology, 2007; 5:873-882,

http://www.niaid.nih.gov/topics/leishmaniasis/pages/lifecycle.aspx

www.nlm.nih.gov/medlineplus/ency/article/001386.

Marleen Boelaert, Sujit Bhattacharya, Francois Chappuis, Sayda H. EI Safi, Asrat Hailu, Dinesh Mondal, Suman Rijal, Shyam Sundar, Monique Wasunna & Rosanna W. Peeling. Evaluation of rapid diagnostic tests: visceral leishmaniasis, Nature Reviews Microbiology, 2007; S30-S39.

Desjeux P., Leishmaniasis; Current situation and new perspectives, comparative immunology, microbiology & infectious diseases, 2004; 27(5):305-318.

Webster’s New International Dictionary of the English Language, 1937, Merriam Company, Springfield, Mass.

Romano AH, Conway T., Evolution of carbohydrate metabolic pathways. Res Microbiol. 1996; 147(6-7):448-55.

Pancholi V, Multifunctional a-enolase: Its role in disease, Cell Mol Life Sci. 2001; 58(7):902-20.

Hoorn RK, Flickweert JP, Staal GE, Purification and properties of enolase of human erythroctyes, Int J Biochem 1974; 5:845-52.

Verlinde C. L., Hannaert V., Blonski C., Willson M., Perie J.J., Fothergill-Gilmore L.A., Opperdoes F. R., Gelb M.H., Hol W. G., Michles P.A., Glycolysis as a target for the design of new anti-trypansome drugs, Drug Resist Updat, 2001; 4(1):50-65.

Published

2018-12-12
Statistics
Abstract Display: 231
PDF Downloads: 388

How to Cite

1.
Mahato J, Sivaperumal R. 2D-Molecular homology modeling of selected Enolase enzyme for Leishmaniasis. J. Drug Delivery Ther. [Internet]. 2018 Dec. 12 [cited 2026 Jan. 21];8(6-s):221-3. Available from: https://jddtonline.info/index.php/jddt/article/view/2117

How to Cite

1.
Mahato J, Sivaperumal R. 2D-Molecular homology modeling of selected Enolase enzyme for Leishmaniasis. J. Drug Delivery Ther. [Internet]. 2018 Dec. 12 [cited 2026 Jan. 21];8(6-s):221-3. Available from: https://jddtonline.info/index.php/jddt/article/view/2117